Discusses advances in treating a common and serious complication of allergic asthma.

What is it about?

Treating allergic bronchopulmonary aspergillosis - ABPA - involves many components, including correctly diagnosing this complicaion of asthma or cystic fibrosis - and then judiciously choosing among a variety of potential treatments including oral or intravenous steroids, oral or inhaled antifungals, or immunomodulating monoclonal antibodies.

Featured Image

Why is it important?

ABPA is an underdiagnosed, chronic and potentially progressive combined infectious-allergic lung disorder affecting millions wordwide.